中国实用外科杂志

中国实用外科杂志

• 专题笔谈 • 上一篇    下一篇

具高转移风险肝癌的预测及其多学科综合治疗方式优化选择

戴朝六，贾昌俊   

  1. 中国医科大学附属盛京医院肝胆脾外科，辽宁沈阳110004
  • 出版日期:2016-06-01 发布日期:2016-05-31

  • Online:2016-06-01 Published:2016-05-31

摘要：

肝细胞癌（简称肝癌）是恶性程度最高的常见肿瘤之一。近年来，随着肝癌筛查和以外科为主导的多学科综合治疗体系的建立，接受根治性治疗的病例明显增加，但术后肿瘤转移与复发仍然是影响疗效的瓶颈。如何根据肿瘤的特点、病人的状况，甚至治疗手段本身等多种复杂因素，综合预测肝癌的转移复发风险，针对具高转移复发风险病人，进一步优化个体化的多学科综合治疗方式，是提高肝癌总体疗效的重要途径。

关键词: 肝癌, 肝切除, 复发, 多学科综合治疗协作组

Abstract:

Prediction and optimal selection of multidisciplinary comprehensive treatment for hepatocellular carcinoma with high risk of recurrence and metastasis        DAI Chao-liu，JIA Chang-jun. Department of Hepatobiliary and Splenic Surgery，Shengjing Hospital of China Medical University，Shenyang 11004，China
Corresponding author：DAI Chao-liu，E-mail：daicl@
sj-hospital.org
Abstract    Hepatocellular carcinoma (HCC) is one of the most malignant tumors. In recent years，along with the establishment of the screening for HCC and the multidisciplinary treatment system with surgery as the leading factor, patients underwent radical surgical treatment were increased significantly. However, postoperative tumor metastasis and relapse are still the bottleneck effect. According to many kinds of complex factors such as characteristics of the tumor，the patient's condition and treatment means itself and so on，the comprehensive prediction of HCC metastasis and recurrence should be developed urgently for the patients with high metastasis and recurrence risk. Optimization of individual multidisciplinary therapy is an important way to improve the overall efficacy of HCC.

Key words: hepatocellular carcinoma, hepatectomy, recurrence, multi-disciplinary team